4DMedical Limited

4DMedical Limited is an Australian-based medical technology company specializing in four-dimensional lung imaging solutions for respiratory diagnostics. It develops and commercializes XV Technology, an FDA-cleared platform that uses patented algorithms to convert X-ray and CT scans into quantitative data on regional lung airflow, ventilation, and function. Key products include XV Lung Ventilation Analysis Software (XV LVAS), which analyzes fluoroscopy images via a software-as-a-service model to assess conditions like asthma, COPD, cystic fibrosis, and lung cancer; CT Lung Ventilation Analysis Software (CT LVAS), processing CT scans for functional insights; the XV Scanner, a dedicated zero-contrast lung function scanner; and Permetium, a multi-function system for pulmonary investigations. Following its acquisition of Imbio, 4DMedical offers AI-driven cardiothoracic imaging tools, providing comprehensive structural and functional lung analysis. The company operates in Australia and the United States, with offices in Melbourne and Los Angeles, partnering with radiology networks, research institutions, and healthcare providers to enhance diagnosis and treatment of pulmonary diseases. Incorporated in 2012 and headquartered in Carlton, Australia, 4DMedical plays a pivotal role in advancing non-invasive respiratory imaging technologies.